A number of targeted anticancer compounds are now in clinical testing through our own product programs and those of our partners. Information on the relevant subtypes of each cancer can be found in the discussion of each compound.
Kadcyla® is a registered trademark of Genentech, a member of the Roche Group.
* Therapeutic antibody
NHL: non-Hodgkin lymphoma AML: acute myeloid leukemia mBC: metastatic breast cancer BC: breast cancer
Based on information on clinicaltrials.gov or other public disclosures.
Last updated: January 29, 2016